The Intravenous Immunoglobulin Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Intravenous Immunoglobulin Market?
The market size of intravenous immunoglobulin has been on an upward trend. It is expected to increase from $14.66 billion in 2024 to $15.72 billion in 2025. The compound annual growth rate (CAGR) during this period is projected to be 7.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Intravenous Immunoglobulin Industry?
The Intravenous Immunoglobulin market is expected to reach a size of $22.01 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.8%.
Download Your Free Sample of the 2025 Intravenous Immunoglobulin Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Intravenous Immunoglobulin Market?
The key drivers in the intravenous immunoglobulin market are:
• Rise in autoimmune disorder incidence
• Advancements and ongoing research in the field of immunology
• Increase in healthcare expenditures
• Innovations and advancements in immunoglobulin therapeutic products
Global Market Segmentation: Identifying Major Intravenous Immunoglobulin Industry Segments
The intravenous immunoglobulin market covered in this report is segmented –
1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications
4) By End-User: Hospitals, Clinics, Home Care
Pre-order the 2025 Intravenous Immunoglobulin Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Intravenous Immunoglobulin Market?
The key trends in the intravenous immunoglobulin market are:
• Primary immunodeficiency disorders treatment is an emerging trend shaping the future of intravenous immunoglobulin market.
• Rapid technological innovations are significantly influencing market trends.
• Strategic collaborations and partnerships are becoming more prevalent in this market.
• Advancements in manufacturing processes and immunotherapy are notable emerging trends.
Who Are the Top Competitors & Leading Players in the Intravenous Immunoglobulin Market?
Major companies in the intravenous immunoglobulin market are:
• Bio Products Laboratory Limited
• Biotest AG
• China Biologic Products Holdings Inc.
• CSL Behring
• Grifols S.A.
• Kedrion SpA
• Shanghai RAAS Blood Products Co. Ltd.
• Octapharma AG
• Takeda Pharmaceutical Company Limited
• Baxter International Inc.
• LFB Biotechnologies SAS
• BDI Pharma Inc.
• Hualan Biological Engineering Inc.
• ADMA Biologics Inc.
• Bharat Serums and Vaccines Limited
• Sanquin Plasma Products B.V.
• Prothya Biosolutions B.V.
• Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.
• Pfizer Inc.
• Kedrion Biopharma
• Intas Pharmaceuticals
• Octapharma Pharmazeutika Produktionsges.m.b.H.
• GC Pharma
• Grifols Biologicals Inc.
• Kamada Ltd.
• LFB USA
• Octapharma Plasma Inc.
• Panacea Biotec Ltd.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the intravenous immunoglobulin market in 2024
